These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26719290)

  • 21. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.
    Contestabile A; Fila T; Bartesaghi R; Contestabile A; Ciani E
    J Neurochem; 2006 Apr; 97(2):515-26. PubMed ID: 16539660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis.
    Orciani C; Hall H; Pentz R; Foret MK; Do Carmo S; Cuello AC
    J Neurochem; 2022 Oct; 163(2):149-167. PubMed ID: 35921478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease.
    Kwakowsky A; Milne MR; Waldvogel HJ; Faull RL
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
    Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
    Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal and brain region-specific elevations of soluble Amyloid-β
    Tallino S; Winslow W; Bartholomew SK; Velazquez R
    Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.
    Strupp BJ; Powers BE; Velazquez R; Ash JA; Kelley CM; Alldred MJ; Strawderman M; Caudill MA; Mufson EJ; Ginsberg SD
    Curr Alzheimer Res; 2016; 13(1):97-106. PubMed ID: 26391046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.
    Ahmadian SS; Rezvanian A; Peterson M; Weintraub S; Bigio EH; Mesulam MM; Geula C
    Neurobiol Aging; 2015 Dec; 36(12):3163-3170. PubMed ID: 26417681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
    Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC
    Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.
    Hunter CL; Bimonte HA; Granholm AC
    Behav Brain Res; 2003 Jan; 138(2):121-31. PubMed ID: 12527443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.
    Belichenko PV; Madani R; Rey-Bellet L; Pihlgren M; Becker A; Plassard A; Vuillermot S; Giriens V; Nosheny RL; Kleschevnikov AM; Valletta JS; Bengtsson SK; Linke GR; Maloney MT; Hickman DT; Reis P; Granet A; Mlaki D; Lopez-Deber MP; Do L; Singhal N; Masliah E; Pearn ML; Pfeifer A; Muhs A; Mobley WC
    PLoS One; 2016; 11(3):e0152471. PubMed ID: 27023444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.
    Martinez JL; Zammit MD; West NR; Christian BT; Bhattacharyya A
    Front Aging Neurosci; 2021; 13():703876. PubMed ID: 34322015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome.
    Kirstein M; Cambrils A; Segarra A; Melero A; Varea E
    Neurochem Res; 2022 Oct; 47(10):3076-3092. PubMed ID: 35767135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
    Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
    Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.